Daniel E. Geffken's Insider Trades & SAST Disclosures
Daniel E. Geffken's most recent trade in CalciMedica Inc was a trade of 10,000 Warrant done . Disclosure was reported to the exchange on May 17, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel E. Geffken.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CalciMedica Inc | Daniel E. Geffken | Interim CFO | 17 May 2024 | 10,000 | 10,000 | - | - | Warrant | ||
| Windtree Therapeutics Inc | Daniel E. Geffken | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 3,050 | 3,050 | - | - | Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | Daniel E. Geffken | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,033 | 2,175 (0%) | 0% | 0 | Common Stock | |
| CalciMedica Inc | Daniel E. Geffken | Interim CFO | 20 Mar 2023 | 11,520 | 11,520 | - | - | Warrant | ||
| CalciMedica Inc | Daniel E. Geffken | Interim CFO | 20 Mar 2023 | 5,760 | 5,760 | - | - | Warrant | ||
| Windtree Therapeutics Inc | Daniel E. Geffken | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | Daniel E. Geffken | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 5,000 | 7,069 (0%) | 0% | 0 | Common Stock | |
| Windtree Therapeutics Inc | Daniel E. Geffken | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | Daniel E. Geffken | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges